HER2, AR protein expression and chromosomal instability in circulating tumor cells (CTCs) of metastatic breast cancer (MBC) patients (pts)

被引：0
|
作者：
Ontiveros, Priscilla [1 ]
Landaverde, Connie [1 ]
Levin, Maren K. [2 ]
Hippely, Sarah [2 ]
Landers, Mark [1 ]
Wang, Yipeng [1 ]
Dittamore, Ryan [1 ]
O'Shaughnessy, Joyce A. [2 ]
机构：
[1] Epic Sci, San Diego, CA USA
[2] Baylor Scott & White Res Inst, Dallas, TX USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-457
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
457
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Reassessment of HER2 status in breast cancer patients at the time of metastatic disease by serum HER2 and HER2 status of circulating tumor cells
    Fehm, Tania
    TUMOR BIOLOGY, 2007, 28 : 22 - 22
  • [32] Efficacy it eribulin in patients (pts) with metastatic breast cancer (MBC): A pooled Analysis by HER2 and ER status
    Kaufman, Peter
    Twelves, Chris
    Cortes, Javier
    Vandat, Linda T.
    Olivo, Martin
    He, Yi
    Awada, Ahmad
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (26)
  • [33] Efficacy of eribulin in patients (pts) with metastatic breast cancer (MBC): a pooled analysis by HER2 and ER status
    Twelves, C.
    Cortes, J.
    Vahdat, L.
    Olivo, M.
    He, Y.
    Kaufman, P. A.
    Awada, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 261 - 262
  • [34] HER-2 expression on circulating tumor cells in metastatic breast cancer
    Hayashi, H.
    Yagata, H.
    Hamaoka, T.
    Sarumaru, S.
    Tsugawa, K.
    Yoshida, A.
    Tsunoda-Shimizu, H.
    Suzuki, K.
    Shimada, M.
    Shimoda, Y.
    Nakamura, S.
    CANCER RESEARCH, 2009, 69 (02) : 306S - 307S
  • [35] HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
    Tanja Fehm
    Volkmar Müller
    Bahriye Aktas
    Wolfgang Janni
    Andreas Schneeweiss
    Elmar Stickeler
    Claus Lattrich
    Christian R. Löhberg
    Erich Solomayer
    Brigitte Rack
    Sabine Riethdorf
    Christoph Klein
    Christian Schindlbeck
    Kerstin Brocker
    Sabine Kasimir-Bauer
    Diethelm Wallwiener
    Klaus Pantel
    Breast Cancer Research and Treatment, 2010, 124 : 403 - 412
  • [36] HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
    Fehm, Tanja
    Mueller, Volkmar
    Aktas, Bahriye
    Janni, Wolfgang
    Schneeweiss, Andreas
    Stickeler, Elmar
    Lattrich, Claus
    Loehberg, Christian R.
    Solomayer, Erich
    Rack, Brigitte
    Riethdorf, Sabine
    Klein, Christoph
    Schindlbeck, Christian
    Brocker, Kerstin
    Kasimir-Bauer, Sabine
    Wallwiener, Diethelm
    Pantel, Klaus
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (02) : 403 - 412
  • [37] Prospective Validation and Characterization of HER2 Positive Circulating Tumor Cells in Patients with HER2 Negative Metastatic Breast Cancer.
    Olson, E. M.
    Flores, L. M.
    Najita, J. S.
    Curley, C.
    Jeong, J.
    Murray, K.
    Savoie, J. J.
    Winer, E. P.
    Krop, I. E.
    CANCER RESEARCH, 2011, 71
  • [38] Circulating tumor cells (CTCs) and molecular subtypes (MST) in a treatment algorithm for metastatic breast cancer (MBC)
    Graham, Mark
    Fleming, Natanya
    Blumenthal, Susan
    Boehlke, Brittani
    Schuur, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [39] Circulating tumor cells (CTCs) biomarker evaluation from patients with metastatic breast cancer (MBC) utilizing the TargetSelector™ platform
    Hamilton, E. P.
    Yardley, D. A.
    Burris, H. A., III
    Shastry, M.
    Huynh, L.
    Bhikha, L.
    Singh, V. M.
    CANCER RESEARCH, 2017, 77
  • [40] Circulating tumor cells (CTCs) and association with survival in molecular subtypes (MST) of metastatic breast cancer (MBC)
    Graham, M.
    Fleming, N.
    Pinto, A.
    Dropkin, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345